Toll Free: 1-888-928-9744

Kite Pharma, Inc. - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Kite Pharma, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Kite Pharma, Inc. - Product Pipeline Review - 2014', provides an overview of the Kite Pharma, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kite Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kite Pharma, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kite Pharma, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Kite Pharma, Inc.'s pipeline products

Reasons to buy

- Evaluate Kite Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kite Pharma, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kite Pharma, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kite Pharma, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kite Pharma, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kite Pharma, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Kite Pharma, Inc. Snapshot 5
Kite Pharma, Inc. Overview 5
Key Information 5
Key Facts 5
Kite Pharma, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Kite Pharma, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Kite Pharma, Inc. - Pipeline Products Glance 10
Kite Pharma, Inc. - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Kite Pharma, Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Kite Pharma, Inc. - Drug Profiles 13
Cell Therapy to Inhibit NY ESO-1 for Cancer 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Cell Therapy to Target EGFR vIII for Glioblastoma 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
KTE-C19 CAR 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
TCR-1 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
TCR-2 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Cell Therapy to Inhibit SSX2 for Solid Tumor 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
TCR-3 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
TCR-4 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Kite Pharma, Inc. - Pipeline Analysis 23
Kite Pharma, Inc. - Pipeline Products by Target 23
Kite Pharma, Inc. - Pipeline Products by Route of Administration 24
Kite Pharma, Inc. - Pipeline Products by Molecule Type 25
Kite Pharma, Inc. - Pipeline Products by Mechanism of Action 26
Kite Pharma, Inc. - Recent Pipeline Updates 27
Kite Pharma, Inc. - Dormant Projects 28
Kite Pharma, Inc. - Locations And Subsidiaries 29
Head Office 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31
List of Tables
Kite Pharma, Inc., Key Information 5
Kite Pharma, Inc., Key Facts 5
Kite Pharma, Inc. - Pipeline by Indication, 2014 7
Kite Pharma, Inc. - Pipeline by Stage of Development, 2014 8
Kite Pharma, Inc. - Monotherapy Products in Pipeline, 2014 9
Kite Pharma, Inc. - Phase II, 2014 10
Kite Pharma, Inc. - Phase I, 2014 11
Kite Pharma, Inc. - Preclinical, 2014 12
Kite Pharma, Inc. - Pipeline by Target, 2014 23
Kite Pharma, Inc. - Pipeline by Route of Administration, 2014 24
Kite Pharma, Inc. - Pipeline by Molecule Type, 2014 25
Kite Pharma, Inc. - Pipeline Products by Mechanism of Action, 2014 26
Kite Pharma, Inc. - Recent Pipeline Updates, 2014 27
Kite Pharma, Inc. - Dormant Developmental Projects,2014 28 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify